Anuh Pharma Limited (BOM:506260)

Market Cap	8.25B -6.2%
Revenue (ttm)	7.78B +6.5%
Net Income	477.70M +23.4%
EPS	4.76 +23.3%
Shares Out	100.22M
PE Ratio	17.27
Forward PE	n/a
Dividend	1.50 (1.82%)
Ex-Dividend Date	Aug 5, 2026

Volume	4,410
Open	83.73
Previous Close	82.09
Day's Range	81.30 - 83.73
52-Week Range	66.72 - 99.50
Beta	0.47
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About Anuh Pharma

Anuh Pharma Limited engages in the manufacture and sale of bulk drugs and chemicals in India. It offers active pharmaceutical ingredients, including macrolides, anti-TB, anti-malarial, anti-hypertension, expectorant, anti-diabetics, anti-bacterial, anti-gout, anti asthmatics, quinolones, anti biotic, anti platelet, anti-histamines, and intermediates; and corticosteroids, including anti-inflammatory, immunosuppressant, anti-pruritic, and anti-mitotic. The company also develops products, such as anticoagulant, antagonist, anti convulsants, anty-u...

• Industry: Pharmaceutical Preparations
• Founded: 1960
• Employees: 323
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 506260

Financial Performance

In fiscal year 2026, Anuh Pharma's revenue was 7.72 billion, an increase of 16.65% compared to the previous year's 6.62 billion. Earnings were 410.46 million, a decrease of -13.32%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Nov 6, 2026

Data Sources Report a data error